Buy a few shares under four cents today.
Company is sponsoring N.F.L. Brain Injury Conference in Minneapolis next week.
Google the recent Seeking Alpha article by bio-tech analyst Jason Napadano.
"Amarantus Teams With Becton, Dickinson For LymPro Development, Seeking PD-LID Candidate"
The company's patented MANF technology could be worth billions in the treatment of a number of neurological diseases such as Alzheimer's and Parkinson's.
The company is sponsoring the N.F.L. Head Injury Symposium being held in Minneapolis later this month.
p.s. Buy a few shares under a dime.
Isn't Arena's market cap speculatively high?
Read the transcript from the most recent quarterly report. Due to the locations of the mines I think the company will be forced to operate at a loss for some time. Political considerations are important.
Average down when it hits the .52-.55 range. Bottom at .46.
I don't see it going lower than that even with a market correction.
Interesting months ahead for GSS and the market.